最新脊髓电刺激新模式对比传统刺激治疗难治性神经病理性疼痛的疗效:临床试验研究方案
本研究为单中心、开放标签、交叉、随机临床试验,旨在探讨最新无感觉异常脊髓电刺激模式(DTM和FAST)对比传统强直刺激治疗神经病理性疼痛的优效性。试验分两阶段:脊髓电刺激试验阶段和系统植入阶段;试验阶段参与者随机分4组接受强直、DTM和FAST刺激,每种刺激2天,间隔1天洗脱,以疼痛视觉模拟量表改善超过33%为疼痛改善。主要分析比较新模式与传统强直刺激的疼痛改善。
要点
- 单中心、开放标签、交叉、随机临床试验,比较DTM和FAST刺激与传统强直刺激对难治性神经病理性疼痛的疗效。
- 每种刺激模式持续2天,模式间设1天刺激关闭洗脱期;疼痛改善定义为疼痛VAS下降超过33%。
- 次要结局包括病因与各刺激模式改善率的关系、DTM与FAST的比较、术前至植入后24个月的评估变化等。
核心结论
- 本研究旨在明确最新脊髓电刺激模式对比传统强直刺激的有效性,并明确哪种刺激模式对哪类病因最有效。
研究设计与样本
- 单中心、开放标签、交叉、随机临床试验,研究脊髓电刺激最新刺激模式对比传统强直刺激治疗神经病理性疼痛的优效性。
- 研究分两步:脊髓电刺激试验(第一步)和脊髓电刺激系统植入(第二步)。
- 试验阶段参与者随机分配至4组接受刺激,包括强直、DTM和FAST;每种刺激进行2天,每种模式前后评估疼痛视觉模拟量表,模式间设1天刺激关闭期以洗脱前一刺激的残余效应。
主要发现
- 疼痛改善定义为疼痛VAS下降超过33%。
- 主要分析在脊髓电刺激试验中比较新模式与传统强直刺激模式的疼痛改善。
- 次要结局包括:(1)病因与各刺激模式改善率的关系;(2)全部病例及按病因比较DTM与FAST刺激模式的疼痛改善;(3)术前至植入后24个月评估项目的变化;(4)与长期效果(持续超过12个月)相关的术前因素;(5)植入后3个月与研究相关的不良事件。
关键数值与推荐
- 疼痛改善定义为疼痛VAS下降超过33%。
- 每种刺激模式持续2天,模式间设1天刺激关闭洗脱期。
- 长期效果定义为持续超过12个月。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Spinal cord stimulation (SCS) is one of the neuromodulation therapies for chronic neuropathic pain. The conventional paresthesia-based SCS involves the application of tonic stimulation that induces a sense of paresthesia. Recently, new SCS stimulation patterns without paresthesia have been developed. Differential target multiplexed (DTM) stimulation and fast-acting subperception therapy (FAST) stimulation are the latest paresthesia-free SCS patterns. METHODS: A single-center, open-label, crossover, randomized clinical trial to investigate the superiority of SCS using the latest new stimulation patterns over conventional tonic stimulation for neuropathic pain is planned. This study consists of two steps: SCS trial (first step) and SCS system implantation (second step). In the SCS trial, participants will be randomly assigned to 4 groups receiving stimulation, including tonic, DTM, and FAST. Each stimulation will then be performed for 2 days, and a visual analog scale (VAS) for pain will be evaluated before and after each stimulation pattern. A stimulation-off period for 1 day is set between each stimulation pattern to wash out the residual previous stimulation effects. Pain improvement is defined as more than 33% reduction in the pain VAS. The primary analysis will compare pain improvement between the new stimulation patterns and the conventional tonic stimulation pattern in the SCS trial. The secondary outcomes will be evaluated as follows: (1) the relationships between causative disease and improvement rate by each stimulation pattern; (2) comparison of pain improvement between the DTM and FAST stimulation patterns in all cases and by causative disease; (3) changes in assessment items preoperatively to 24 months after the implantation; (4) preoperative factors associated with long-term effects defined as continuing for more than 12 months; and (5) adverse events related to this study 3 months after the implantation. DISCUSSION: This study aims to clarify the effectiveness of the latest new stimulation patterns compared to the conventional tonic stimulation. In addition, which stimulation pattern is most effective for which kind of causative disease will be clarified. TRIAL REGISTRATION: Japan Registry of Clinical Trials (jRCT) 1,042,220,094. Registered on 21 November 2022, and last modified on 6 January 2023. jRCT is an approved member of the Primary Registry Network of WHO ICTRP.
引用
- Tanei T, Maesawa S, Nishimura Y, et al. Efficacy of the latest new stimulation patterns of spinal cord stimulation for intractable neuropathic pain compared to conventional stimulation: study protocol for a clinical trial. Trials. 2023. PMID: 37742013. doi:10.1186/s13063-023-07637-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。